FDA Inspection
Jiangxi Tianxin Pharmaceutical Co., Ltd.Jiangxi Tianxin Pharmaceutical Co., Ltd. – FDA Inspection, Feb 2, 2018
Record Details
This FDA Inspection record concerns Jiangxi Tianxin Pharmaceutical Co., Ltd., with an inspection on February 2, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- February 2, 2018
- Product Type
- Human Drugs
- People
- Kara D. Dobbin (Issuing Officer)
- Reba A. Gates (Issuing Officer)
View Company Profile
ID · f1c7536a-ce14-48a7-bcc1-081adcc7422c
Inspection Facts
- Inspection number
- 1042989
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Jiangxi Tianxin Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 19, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 1, 2012 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
Other documents for Jiangxi Tianxin Pharmaceutical Co., Ltd.
- FDA Inspection 1247725 - 2024-07-19
- FDA Inspection 921562 - 2015-04-03
- FDA Inspection 808855 - 2012-11-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.